This NDC is on FDA's drug shortage list (posted Jul 14, 2023)

Product Information

LISDEXAMFETAMINE 10 MG CAPSULE is a generic product labeled by SpecGx LLC, priced at $2.6601 per EA under NDC 00406511101. Its NADAC has been published 144 times since Nov 22, 2023.

FDA first approved this application on Aug 25, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LISDEXAMFETAMINE 10 MG CAPSULE

Lisdexamfetamine Dimesylate
$2.6601per EA
DEA Schedule CII

Strength

10 mg/1

Manufacturer

SpecGx LLC

NDC

00406511101

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA211840

FDA Approved

8/25/2023

TE Code

AB

On Market Since

8/25/2023

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for LISDEXAMFETAMINE 10 MG CAPSULE has been published 144 times since Nov 22, 2023, and over the history we have for it it has declined 54.8%. The table below summarizes its recorded NADAC range and movement.

Current price$2.6601 per EA
All-time high$5.9486 (Mar 13, 2024)
All-time low$2.6601 (Aug 19, 2026)
52-week high$3.5435
52-week low$2.6601
Median price$4.1902
Average price$4.1654
Largest weekly change+34.4% (Jan 17, 2024)
Weeks tracked144
Tracking sinceNov 22, 2023

Price History

1W

-4.5%

1M

-4.5%

3M

-11.2%

6M

-17.5%

1Y

-23.0%

3Y

N/A

5Y

N/A

All

-54.8%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LISDEXAMFETAMINE 10 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 10 MG CAPSULE, manufactured by SpecGx LLC, is $2.6601 per EA (NDC 00406511101), effective Aug 19, 2026.

How has the price of LISDEXAMFETAMINE 10 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for LISDEXAMFETAMINE 10 MG CAPSULE has declined 54.8%. It has been tracked across 144 weekly CMS publications since Nov 22, 2023.

What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 10 MG CAPSULE?

Since Nov 22, 2023, the NADAC for LISDEXAMFETAMINE 10 MG CAPSULE has ranged from a low of $2.6601 (Aug 19, 2026) to a high of $5.9486 (Mar 13, 2024), with a median of $4.1902 per EA.

Are there cheaper alternatives to LISDEXAMFETAMINE 10 MG CAPSULE?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LISDEXAMFETAMINE 10 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures LISDEXAMFETAMINE 10 MG CAPSULE?

LISDEXAMFETAMINE 10 MG CAPSULE (NDC 00406511101) is labeled by SpecGx LLC, and CMS classifies it as a generic product.

Is LISDEXAMFETAMINE 10 MG CAPSULE in shortage?

Yes — NDC 00406511101 is currently listed in FDA's drug shortage database (posted Jul 14, 2023).